Fig. 6From: Highly sensitive Curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer's disease via NLRP3-inhibitionEffects of Cur-MNPs treatment on neural protection and inflammation. A WB analysis of DCX, BDNF, IL-18, NLRP3 and CD68 after treatment with Cur-MNPs. B–F Quantitative analysis of DCX, BDNF, IL-18, NLRP3 and CD68 expression. p = NS indicates nonsignificant. *p < 0.05, **p < 0.01, ***p < 0.001 versus former group, #p < 0.05, ##p < 0.01, ###p < 0.001 versus TG groupBack to article page